Dr. Anish J. Mehta, MD

Dr. Mehta practices at Newton-Wellesley Hospital in Newton, Massachusetts, part of Mass General Brigham.

Dr. Mehta's NPI, 1841672672, was assigned on June 29, 2015. Dr. Mehta graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2015. Dr. Mehta holds New York license 296482.

Dr. Mehta's primary practice is Newton-Wellesley Hospital, at 2014 Washington Street, Newton, MA 02462 in Middlesex County. The practice phone is (617) 243-6000.

Dr. Mehta's primary practice is Newton-Wellesley Hospital in Newton, Massachusetts, part of Mass General Brigham. Dr. Mehta is also affiliated with Massachusetts General Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Mehta to 2 more medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Mehta's licenses on file in 7 states: New York, California, District of Columbia, Illinois, Massachusetts, Maryland and Virginia.

CMS data shows 93 Medicare services from Dr. Mehta across 1 procedure code in 2024, for 54 Medicare patients. Medicare paid $9,428 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 4.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 79, with 33% women.

In 2019, Dr. Mehta wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $252 in total drug cost. In 2018, CMS named 114 claims across 7 drugs.

Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Dr. Mehta, published from 2010 to 2018. 2016 was the busiest year, with 6. The most frequent topics are Double-Blind Method, Cyclooxygenase 2 Inhibitors and Pyridines. Dr. Mehta has published most often in Curr Med Res Opin. Dr. Mehta's most frequent co-authors are Selwyn Aubrey Stoch, MD, Denise Ann Morris, MD and Kara Leanne Bickham, MD.

CMS Open Payments shows 3 general payments to Dr. Mehta from 1 drug or device company from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Mayne Pharma Inc. paid the most, $65.

Dr. Mehta graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2015.